Key result
Review summarizes current anticoagulation guidelines and new DOAC data in CVD management.
This review summarizes evidence-based guidelines and new data for anticoagulant use across various cardiovascular conditions.
May guide DOAC selection in CVD; leaves open need for updated RCTs to refine recommendations.
Anticoagulation has multiple roles in the treatment of cardiovascular disease, including in management of acute myocardial infarction, during percutaneous coronary intervention, as stroke prophylaxis in patients with atrial arrhythmias, and in patients with mechanical heart valves. Clinical anticoagulation choices in the aforementioned diseases vary widely, due to conflicting data to support established agents and the rapid evolution of evidence-based practice that parallels more widespread use of novel oral anticoagulants. This review concisely summarizes evidence-based guidelines for anticoagulant use in cardiovascular disease, and highlights new data specific to direct oral anticoagulants.
No takes yet. Share an insight, caveat, or question.
Larson et al. (2018) conducted a review in Cardiovascular disease. Anticoagulation was evaluated. Anticoagulation guidelines and new data specific to direct oral anticoagulants in cardiovascular disease management are summarized in this review.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: